Laboratory Monitoring of P2Y12 Inhibitors: a Position Statement of the Platelet Physiology Scientific and Standardization Committee

Research output: Contribution to journal › Article › peer-review

Authors

  • Andrew L Frelinger
  • Christian Gachet
  • Andrew Mumford
  • Patrizia Noris
  • Diego Mezzano
  • P Gresele

Colleges, School and Institutes

External organisations

  • Harvard Medical School
  • University of Perugia

Details

Original languageEnglish
Pages (from-to)2374-2346
JournalJournal of thrombosis and haemostasis : JTH
Volume16
Early online date4 Sep 2018
Publication statusE-pub ahead of print - 4 Sep 2018

Keywords

  • bleeding, clopidogrel, monitoring, Prasugrel, recommendations, thrombosis, ticagrelor
Save citation Saved citations (0)

Copy the text from this field...

View graph of relations

Documents

  • Frelinger_et_al_Laboratory Monitoring of P2Y12 Inhibitors_JTH

    Rights statement: This is the peer reviewed version of the following article: Frelinger et al (2018), Laboratory monitoring of PSY12 inhibitors: communication from the SSC of the ISTH, in Journal of Thrombosis and Haemostasis, Vol 16, 2341-2346, which has been published in final form at doi.org/10.1111/jth.14282. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions.

    Accepted author manuscript, 85.9 KB, PDF document

    Licence: None: All rights reserved Show licence

DOI

By the same authors

The state of the art and future of PRP therapy

Paul Harrison, 17 Dec 2020, In: Platelets. 32, 2, p. 1-2 2 p.

Research output: Contribution to journal › Editorial › peer-review